EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,786,000 | -24.4% | 57,525 | 0.0% | 0.05% | -12.1% |
| Q1 2022 | $2,362,000 | -5.6% | 57,525 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $2,501,000 | -13.2% | 57,525 | 0.0% | 0.06% | -17.1% |
| Q3 2021 | $2,880,000 | -18.3% | 57,525 | +2.9% | 0.07% | -13.6% |
| Q2 2021 | $3,523,000 | -32.2% | 55,925 | 0.0% | 0.08% | -34.7% |
| Q1 2021 | $5,196,000 | -1.1% | 55,925 | -4.6% | 0.12% | -4.6% |
| Q4 2020 | $5,253,000 | -19.5% | 58,625 | -7.1% | 0.13% | -27.4% |
| Q3 2020 | $6,523,000 | +18.5% | 63,125 | -9.3% | 0.18% | +27.0% |
| Q2 2020 | $5,506,000 | +35.3% | 69,625 | -1.0% | 0.14% | +17.5% |
| Q1 2020 | $4,069,000 | +4.7% | 70,325 | -2.4% | 0.12% | +48.1% |
| Q4 2019 | $3,887,000 | -45.5% | 72,045 | -47.2% | 0.08% | -43.8% |
| Q3 2019 | $7,128,000 | +22.8% | 136,344 | +13.5% | 0.14% | +30.9% |
| Q2 2019 | $5,803,000 | -0.5% | 120,110 | +4.1% | 0.11% | +0.9% |
| Q1 2019 | $5,832,000 | – | 115,434 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |